• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

游离脂肪酸与非酒精性脂肪性肝病患者糖尿病发病的相关性:剂量依赖性研究。

Distinct Dose-Dependent Association of Free Fatty Acids with Diabetes Development in Nonalcoholic Fatty Liver Disease Patients.

机构信息

Department of Gastroenterology, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.

Department of Clinical Laboratory, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.

出版信息

Diabetes Metab J. 2021 May;45(3):417-429. doi: 10.4093/dmj.2020.0039. Epub 2021 Mar 15.

DOI:10.4093/dmj.2020.0039
PMID:33705650
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8164943/
Abstract

BACKGROUND

Excessive delivery of free fatty acids (FFAs) to the liver promotes steatosis and insulin resistance (IR), with IR defined as reduced glucose uptake, glycogen synthesis and anti-lipolysis stimulated by normal insulin levels. Whether the associations between FFAs and diabetes development differ between patients with and without nonalcoholic fatty liver disease (NAFLD) remains unclear.

METHODS

Consecutive subjects (2,220 NAFLD subjects and 1,790 non-NAFLD subjects according to ultrasound imaging) were enrolled from the First Affiliated Hospital of Sun Yat-sen University between 2009 and 2019. The homeostasis model assessment of insulin resistance (HOMA-IR) was calculated.

RESULTS

There was an approximate J-shaped relationship between FFA levels and HOMA-IR in the NAFLD group. Higher FFA concentration quartiles were associated with higher risks of IR (odds ratio [OR], 9.24; 95% confidence interval [CI], 6.43 to 13.36), prediabetes (OR, 10.48; 95% CI, 5.66 to 19.39), and type 2 diabetes mellitus (T2DM; OR, 19.43; 95% CI, 12.75 to 29.81) in the NAFLD group but not in the non-NAFLD group. The cut-off points for the FFA levels increased in a stepwise manner in discriminating IR, prediabetes and T2DM (573, 697, and 715 μmol/L) in the NAFLD group but not in non-NAFLD individuals.

CONCLUSION

A distinct dose-dependent relationship of FFA levels was found with IR, prediabetes and T2DM in NAFLD patients. Screening serum FFA levels in NAFLD patients would be valuable in preventing diabetes development.

摘要

背景

过多的游离脂肪酸(FFAs)输送到肝脏会导致脂肪变性和胰岛素抵抗(IR),IR 的定义为正常胰岛素水平下葡萄糖摄取、糖原合成和抗脂肪分解减少。FFAs 与糖尿病发展之间的关联在患有和不患有非酒精性脂肪性肝病(NAFLD)的患者之间是否不同尚不清楚。

方法

中山大学第一附属医院于 2009 年至 2019 年连续纳入了 2220 名符合超声成像标准的 NAFLD 患者和 1790 名非 NAFLD 患者。计算了胰岛素抵抗的稳态模型评估(HOMA-IR)。

结果

在 NAFLD 组中,FFA 水平与 HOMA-IR 之间存在近似的 J 形关系。较高的 FFA 浓度四分位数与 IR(比值比 [OR],9.24;95%置信区间 [CI],6.43 至 13.36)、糖尿病前期(OR,10.48;95%CI,5.66 至 19.39)和 2 型糖尿病(T2DM;OR,19.43;95%CI,12.75 至 29.81)的风险增加相关,但在非 NAFLD 组中并非如此。在 NAFLD 组中,FFA 水平的截断值在区分 IR、糖尿病前期和 T2DM(573、697 和 715 μmol/L)时呈逐步增加趋势,但在非 NAFLD 个体中并非如此。

结论

在 NAFLD 患者中,FFA 水平与 IR、糖尿病前期和 T2DM 之间存在明显的剂量依赖性关系。在 NAFLD 患者中筛查血清 FFA 水平对于预防糖尿病的发生可能具有重要价值。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef02/8164943/c469456b9be0/dmj-2020-0039f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef02/8164943/6c8cf09e8568/dmj-2020-0039f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef02/8164943/fcba28adbcc6/dmj-2020-0039f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef02/8164943/9362b6747165/dmj-2020-0039f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef02/8164943/c469456b9be0/dmj-2020-0039f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef02/8164943/6c8cf09e8568/dmj-2020-0039f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef02/8164943/fcba28adbcc6/dmj-2020-0039f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef02/8164943/9362b6747165/dmj-2020-0039f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef02/8164943/c469456b9be0/dmj-2020-0039f4.jpg

相似文献

1
Distinct Dose-Dependent Association of Free Fatty Acids with Diabetes Development in Nonalcoholic Fatty Liver Disease Patients.游离脂肪酸与非酒精性脂肪性肝病患者糖尿病发病的相关性:剂量依赖性研究。
Diabetes Metab J. 2021 May;45(3):417-429. doi: 10.4093/dmj.2020.0039. Epub 2021 Mar 15.
2
Is HOMA-IR a potential screening test for non-alcoholic fatty liver disease in adults with type 2 diabetes?HOMA-IR能否作为2型糖尿病成年患者非酒精性脂肪性肝病的潜在筛查检测方法?
Eur J Intern Med. 2017 Jun;41:74-78. doi: 10.1016/j.ejim.2017.03.006. Epub 2017 Mar 7.
3
High Prevalence of Nonalcoholic Fatty Liver Disease in Patients with Type 2 Diabetes Mellitus and Normal Plasma Aminotransferase Levels.2型糖尿病且血浆转氨酶水平正常患者中非酒精性脂肪性肝病的高患病率。
J Clin Endocrinol Metab. 2014 Oct 10;100(5). doi: 10.1210/jc.2014-2739.
4
The Relationship between Type 2 Diabetes Mellitus and Non-Alcoholic Fatty Liver Disease Measured by Controlled Attenuation Parameter.通过受控衰减参数测量2型糖尿病与非酒精性脂肪性肝病之间的关系。
Yonsei Med J. 2016 Jul;57(4):885-92. doi: 10.3349/ymj.2016.57.4.885.
5
Prevalence of prediabetes and diabetes and metabolic profile of patients with nonalcoholic fatty liver disease (NAFLD).非酒精性脂肪性肝病(NAFLD)患者的糖尿病前期和糖尿病患病率及代谢特征。
Diabetes Care. 2012 Apr;35(4):873-8. doi: 10.2337/dc11-1849. Epub 2012 Feb 28.
6
Serum phospholipid omega-3 polyunsaturated fatty acids and insulin resistance in type 2 diabetes mellitus and non-alcoholic fatty liver disease.2型糖尿病和非酒精性脂肪性肝病患者血清磷脂ω-3多不饱和脂肪酸与胰岛素抵抗
J Diabetes Complications. 2014 Sep-Oct;28(5):711-4. doi: 10.1016/j.jdiacomp.2014.04.008. Epub 2014 Apr 18.
7
IMPACT OF TYPE 2 DIABETES ON NONALCOHOLIC STEATOHEPATITIS AND ADVANCED FIBROSIS IN PATIENTS WITH NONALCOHOLIC FATTY LIVER DISEASE.2 型糖尿病对非酒精性脂肪性肝病患者非酒精性脂肪性肝炎和肝纤维化进展的影响。
Endocr Pract. 2020 Apr;26(4):444-453. doi: 10.4158/EP-2019-0342. Epub 2020 Jan 22.
8
Crosstalk between adipose tissue insulin resistance and liver macrophages in non-alcoholic fatty liver disease.非酒精性脂肪性肝病中脂肪组织胰岛素抵抗与肝巨噬细胞的串扰。
J Hepatol. 2019 Nov;71(5):1012-1021. doi: 10.1016/j.jhep.2019.06.031. Epub 2019 Jul 10.
9
Serum adipocyte fatty acid-binding protein levels: An indicator of non-alcoholic fatty liver disease in Chinese individuals.血清脂肪细胞脂肪酸结合蛋白水平:中国人非酒精性脂肪肝的一个指标。
Liver Int. 2019 Mar;39(3):568-574. doi: 10.1111/liv.14021. Epub 2018 Dec 28.
10
High Prevalence of Nonalcoholic Fatty Liver Disease in Patients With Type 2 Diabetes Mellitus and Normal Plasma Aminotransferase Levels.2型糖尿病且血浆转氨酶水平正常患者中非酒精性脂肪性肝病的高患病率
J Clin Endocrinol Metab. 2015 Jun;100(6):2231-8. doi: 10.1210/jc.2015-1966. Epub 2015 Apr 17.

引用本文的文献

1
Prognostic value of ALBI score for all-cause mortality in metabolic associated fatty liver disease patients: a cohort study from NHANES 2003-2018.ALBI评分对代谢相关脂肪性肝病患者全因死亡率的预后价值:一项基于2003 - 2018年美国国家健康与营养检查调查(NHANES)的队列研究
BMC Gastroenterol. 2025 Aug 7;25(1):561. doi: 10.1186/s12876-025-04117-1.
2
Intracellular fatty acid levels differentially impact target silencing by FDA-approved siRNA drugs.细胞内脂肪酸水平对FDA批准的小干扰RNA(siRNA)药物的靶点沉默有不同影响。
Biochem Pharmacol. 2025 Jul 27;242(Pt 2):117192. doi: 10.1016/j.bcp.2025.117192.
3
Human genetics of metabolic dysfunction-associated steatotic liver disease: from variants to cause to precision treatment.

本文引用的文献

1
Excess Accumulation of Lipid Impairs Insulin Sensitivity in Skeletal Muscle.脂质蓄积过度会损害骨骼肌的胰岛素敏感性。
Int J Mol Sci. 2020 Mar 12;21(6):1949. doi: 10.3390/ijms21061949.
2
2. Classification and Diagnosis of Diabetes: .2. 糖尿病的分类和诊断: 。
Diabetes Care. 2020 Jan;43(Suppl 1):S14-S31. doi: 10.2337/dc20-S002.
3
Effect of Metabolic Traits on the Risk of Cirrhosis and Hepatocellular Cancer in Nonalcoholic Fatty Liver Disease.代谢特征对非酒精性脂肪性肝病患者肝硬化和肝细胞癌风险的影响。
代谢功能障碍相关脂肪性肝病的人类遗传学:从变异到病因再到精准治疗
J Clin Invest. 2025 Apr 1;135(7):e186424. doi: 10.1172/JCI186424.
4
Research progress on the relationship between free fatty acid profile and type 2 diabetes complicated by coronary heart disease.游离脂肪酸谱与2型糖尿病合并冠心病关系的研究进展
Front Endocrinol (Lausanne). 2024 Dec 6;15:1503704. doi: 10.3389/fendo.2024.1503704. eCollection 2024.
5
Nutrition, health benefits, and processing of sand rice (): Comparisons with quinoa and buckwheat.沙米的营养、健康益处及加工:与藜麦和荞麦的比较
Food Sci Nutr. 2024 Aug 27;12(10):7060-7074. doi: 10.1002/fsn3.4429. eCollection 2024 Oct.
6
Global epidemiology of type 2 diabetes in patients with NAFLD or MAFLD: a systematic review and meta-analysis.非酒精性脂肪性肝病或代谢相关脂肪性肝病患者 2 型糖尿病的全球流行病学:系统评价和荟萃分析。
BMC Med. 2024 Mar 6;22(1):101. doi: 10.1186/s12916-024-03315-0.
7
Experimental model and novel therapeutic targets for non-alcoholic fatty liver disease development.非酒精性脂肪性肝病发生的实验模型及新型治疗靶点
Korean J Physiol Pharmacol. 2023 Jul 1;27(4):299-310. doi: 10.4196/kjpp.2023.27.4.299.
8
Metabolic Dysfunction-Associated Fatty Liver Disease and Mortality: A Population-Based Cohort Study.代谢功能障碍相关脂肪性肝病与死亡率:一项基于人群的队列研究。
Diabetes Metab J. 2023 Mar;47(2):220-231. doi: 10.4093/dmj.2021.0327. Epub 2023 Jan 12.
9
Mongolian medicine in treating type 2 diabetes mellitus combined with nonalcoholic fatty liver disease via FXR/LXR-mediated P2X7R/NLRP3/NF-κB pathway activation.蒙医药通过FXR/LXR介导的P2X7R/NLRP3/NF-κB通路激活治疗2型糖尿病合并非酒精性脂肪性肝病
Chin Herb Med. 2022 Jul 19;14(3):367-375. doi: 10.1016/j.chmed.2022.06.003. eCollection 2022 Jul.
10
Triglyceride Glucose-Waist Circumference Is Superior to the Homeostasis Model Assessment of Insulin Resistance in Identifying Nonalcoholic Fatty Liver Disease in Healthy Subjects.甘油三酯-血糖-腰围在识别健康受试者非酒精性脂肪性肝病方面优于胰岛素抵抗稳态模型评估。
J Clin Med. 2021 Dec 23;11(1):41. doi: 10.3390/jcm11010041.
Hepatology. 2020 Mar;71(3):808-819. doi: 10.1002/hep.31014. Epub 2020 Feb 26.
4
Elevated free fatty acid level is associated with insulin-resistant state in nondiabetic Chinese people.游离脂肪酸水平升高与非糖尿病中国人的胰岛素抵抗状态相关。
Diabetes Metab Syndr Obes. 2019 Jan 17;12:139-147. doi: 10.2147/DMSO.S186505. eCollection 2019.
5
Longitudinal correlations between MRE, MRI-PDFF, and liver histology in patients with non-alcoholic steatohepatitis: Analysis of data from a phase II trial of selonsertib.非酒精性脂肪性肝炎患者的 MRE、MRI-PDFF 与肝组织学的纵向相关性:selonsertib 二期临床试验数据分析。
J Hepatol. 2019 Jan;70(1):133-141. doi: 10.1016/j.jhep.2018.09.024. Epub 2018 Oct 4.
6
Diabetes, Plasma Glucose, and Incidence of Fatty Liver, Cirrhosis, and Liver Cancer: A Prospective Study of 0.5 Million People.糖尿病、血浆葡萄糖与脂肪肝、肝硬化和肝癌的发病风险:一项涉及 50 万人的前瞻性研究。
Hepatology. 2018 Oct;68(4):1308-1318. doi: 10.1002/hep.30083.
7
Twenty-five-year trajectories of insulin resistance and pancreatic β-cell response and diabetes risk in nonalcoholic fatty liver disease.非酒精性脂肪性肝病患者的胰岛素抵抗、胰岛β细胞反应和糖尿病风险的 25 年变化轨迹。
Liver Int. 2018 Nov;38(11):2069-2081. doi: 10.1111/liv.13747. Epub 2018 Apr 24.
8
Expert panel consensus recommendations for home blood pressure monitoring in Asia: the Hope Asia Network.亚洲家庭血压监测专家共识推荐:希望亚洲网络。
J Hum Hypertens. 2018 Apr;32(4):249-258. doi: 10.1038/s41371-017-0025-y. Epub 2018 Jan 31.
9
Global aetiology and epidemiology of type 2 diabetes mellitus and its complications.2 型糖尿病及其并发症的全球病因学和流行病学。
Nat Rev Endocrinol. 2018 Feb;14(2):88-98. doi: 10.1038/nrendo.2017.151. Epub 2017 Dec 8.
10
Optimal threshold of controlled attenuation parameter with MRI-PDFF as the gold standard for the detection of hepatic steatosis.以 MRI-PDFF 为金标准检测肝脂肪变时的最佳受控衰减参数阈值。
Hepatology. 2018 Apr;67(4):1348-1359. doi: 10.1002/hep.29639. Epub 2018 Feb 19.